AIRESCAN Stock Review (19/12/2022)

Hi everyone.

On 19/12/2022, our system had provided a few picks and the results are as below:

KMX – (Sell)  – Profit

VEEV   – (Sell) –  Profit

The blue-chip Dow and the S&P 500 were trading around the flatline with some negative bias on Monday, while the Nasdaq 100 was down roughly 0.5%, as worries over the global economy’s health and the path for interest rates continue to hang over the markets.

Let’s review our stock picks on Monday.

Call for sell for KMX which resulted in a profit. Our system entered the market at $60.92 and made a call to profit at $60.30.

CarMax, Inc., together with its subsidiaries, operates as a retailer of used vehicles in the United States. The company operates through two segments, CarMax Sales Operations and CarMax Auto Finance. It offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; and extended protection plans to customers at the time of sale, as well as sells vehicles that are approximately 10 years old and has more than 100,000 miles through wholesale auctions.

Call for sell for VEEV which resulted in a profit. Our system entered the market at $168.04 and made a call to profit at $166.00 which is our trailing stop loss.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety.

Stay tuned for more of our stock picks.